The Europe opioids drugs market is evaluated to record a CAGR of 2.45% during the forecast period of 2019-2028. The factors leading to the growth of the market in the region are high demand for opioid drugs due to the high incidence of cancer and chronic pain patients, and less regulatory control on opioid drugs. The Europe opioids drugs market is further studied by segmenting the region into countries such as Germany, Russia, Belgium, France, the UK, Italy, Poland, and the rest of Europe. In the UK, there is a steady rise in prescription opioids.

EUROPE OPIOIDS DRUGS MARKET FORECAST 2019-2028

Europe Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction) and by Geography

Request free sample

The Europe opioids drugs market is evaluated to record a CAGR of 2.45% during the forecast period of 2019-2028. The factors leading to the growth of the market in the region are high demand for opioid drugs due to the high incidence of cancer and chronic pain patients, and less regulatory control on opioid drugs.
Europe Opioids Drug Marke

To know more about this report, request a free sample copy

The Europe opioids drugs market is further studied by segmenting the region into countries such as Germany, Russia, Belgium, France, the UK, Italy, Poland, and the rest of Europe. In the UK, there is a steady rise in prescription opioids. However, the opioid crisis is avoided owing to the universally accessible pain management services, which are highly active under NHS all over the United Kingdom to support opioid-addicted patients. Germany is also at risk of suffering an opioid epidemic. As per EMCDDA, in 2017, the high-risk opioid users were 160,322, which is about 3 per 1000 population. The cost of prescribed opioids is largely reimbursed by statutory and private health insurance companies.

In France, there is a constant increase in opioids abuse across the country, which is giving rise to an epidemic like situation. As per EDMCCA, it was estimated 349 people died of an opioid overdose among the population of 66 million people. Medicines to alleviate breathing difficulty, relieve pain, and sedate coronavirus patients are in high demand. In countries like Italy, the rate of opioid users is about 5.2 per 1000. The ongoing education programs and a surge in government initiatives regarding opioid usage are the major factors deciding the effective growth of the market.

Hikma Pharmaceuticals develops, manufacture, and markets a broad range of branded and non branded generic pharmaceutical products. The product portfolio of the company includes, Butorphanol Tartrate Nasal Spray, Fentanyl Citrate Injection, Hydromorphone HCl Injection, Methadone HCl Oral Concentrate, Morphine Sulfate Oral Solution, Oxycodone HCl Oral Solution, Oxymorphone Hydrochloride Tablets, etc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
        • ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
        • USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
        • GROWING OCCURRENCE OF CHRONIC PAIN
      •    KEY RESTRAINTS
        • MISUSE OF OPIOIDS
        • STRINGENT REGULATORY FRAMEWORK
    1. KEY ANALYTICS
      • KEY INVESTMENT INSIGHTS
      •    PORTER’S FIVE FORCE ANALYSIS
        • BUYER POWER
        • SUPPLIER POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • REGULATORY FRAMEWORK
      • TECHNOLOGICAL ADVANCEMENT
    2. MARKET BY PRODUCT
      • BUPRENORPHINE
      • FENTANYL
      • HYDROCODONE
      • MORPHINE
      • OXYCODONE
      • TRAMADOL
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      •    PAIN RELIEF
        • CANCER PAIN
        • POSTOPERATIVE PAIN MANAGEMENT
        • LOW BACK PAIN
        • ORTHOPEDIC
        • FIBROMYALGIA
        • NEUROPATHIC
      • ANESTHESIA
      • COUGH SUPPRESSION
      • DIARRHEA SUPPRESSION
      • DEADDICTION
    4. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • THE UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    1. COMPANY PROFILES
      • ACURA PHARMACEUTICALS INC
      • ALLERGAN PLC
      • BIODELIVERY SCIENCES INTERNATIONAL INC
      • CIPHER PHARMACEUTICALS INC
      • COLLEGIUM PHARMACEUTICAL INC
      • DAIICHI SANKYO INC
      • EGALET CORP
      • HIKMA PHARMACEUTICALS PLC
      • INDIVIOR INC
      • JANSSEN PHARMACEUTICALS INC
      • JOHNSON & JOHNSON
      • LANNETT CO. INC
      • LUPIN LTD
      • MYLAN NV
      • PFIZER INC
      • PURDUE PHARMA LP
      • SANOFI-AVENTIS S.A
      • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
      • TEVA PHARMACEUTICAL INDUSTRIES LTD

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – OPIOIDS DRUGS

    TABLE 2:  EUROPE OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 3:  EUROPE OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 4: EUROPE OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: EUROPE OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: EUROPE PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):

    TABLE 7: EUROPE PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION):

    TABLE 8: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 9: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    FIGURE LIST 

    FIGURE 1: KEY INVESTMENT INSIGHTS

    FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019

    FIGURE 6: EUROPE OPIOIDS DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)

    FIGURE 7: EUROPE OPIOIDS DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)

    FIGURE 8: EUROPE OPIOIDS DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)

    FIGURE 9: EUROPE OPIOIDS DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)

    FIGURE 10: EUROPE OPIOIDS DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)

    FIGURE 11: EUROPE OPIOIDS DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)

    FIGURE 12: EUROPE OPIOIDS DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)

    FIGURE 13: EUROPE OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019

    FIGURE 14: EUROPE OPIOIDS DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)

    FIGURE 15: EUROPE PAIN RELIEF MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)

    FIGURE 16: EUROPE PAIN RELIEF MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)

    FIGURE 17: EUROPE PAIN RELIEF MARKET, BY LOW BACK PAIN, 2019-2028 (IN $ MILLION)

    FIGURE 18: EUROPE PAIN RELIEF MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)

    FIGURE 19: EUROPE PAIN RELIEF MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)

    FIGURE 20: EUROPE PAIN RELIEF MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)

    FIGURE 21: EUROPE OPIOIDS DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)

    FIGURE 22: EUROPE OPIOIDS DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 23: EUROPE OPIOIDS DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 24: EUROPE OPIOIDS DRUGS MARKET, BY DEADDICTION, 2019-2028 (IN $ MILLION)

    FIGURE 25: EUROPE OPIOIDS DRUGS MARKET, COUNTRY OUTLOOK, 2018 & 2028 (IN %)

    FIGURE 26: THE UNITED KINGDOM OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 27: GERMANY OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 28: FRANCE OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 29: ITALY OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 30: RUSSIA OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 31: BELGIUM OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 32: POLAND OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 33: REST OF EUROPE OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • THE UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    1. MARKET BY PRODUCT
      • BUPRENORPHINE
      • FENTANYL
      • HYDROCODONE
      • MORPHINE
      • OXYCODONE
      • TRAMADOL
      • OTHER PRODUCTS
    2. MARKET BY APPLICATION
      •    PAIN RELIEF
        • CANCER PAIN
        • POSTOPERATIVE PAIN MANAGEMENT
        • LOW BACK PAIN
        • ORTHOPEDIC
        • FIBROMYALGIA
        • NEUROPATHIC
      • ANESTHESIA
      • COUGH SUPPRESSION
      • DIARRHEA SUPPRESSION
      • DEADDICTION

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type